Safety and tolerability of new-generation anti-obesity medications: a narrative review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and tolerability of new-generation anti-obesity medications: a narrative review
Authors
Keywords
-
Journal
POSTGRADUATE MEDICINE
Volume 130, Issue 2, Pages 173-182
Publisher
Informa UK Limited
Online
2018-02-01
DOI
10.1080/00325481.2018.1435129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
- (2017) Carel W le Roux et al. LANCET
- The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study
- (2017) Fatima Cody Stanford et al. Surgery for Obesity and Related Diseases
- The Current Role of Liraglutide in the Pharmacotherapy of Obesity
- (2016) Georgios A. Christou et al. Current Vascular Pharmacology
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
- (2016) W. Timothy Garvey et al. Endocrine Practice
- Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release
- (2016) Bruno Halpern et al. Expert Opinion On Drug Safety
- Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
- (2016) A Blackman et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
- (2016) Emanuele Di Angelantonio et al. LANCET
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s
- (2016) Catherine E. Thomas et al. Obesity
- Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials
- (2016) Neil J. Weissman et al. Obesity
- Why do we need observational studies of everyday patients in the real-life setting?: Table 1
- (2015) Alexander T. Cohen et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacotherapy for the management of obesity
- (2015) Dhiren Patel METABOLISM-CLINICAL AND EXPERIMENTAL
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and tolerability of medications approved for chronic weight management
- (2015) Ken Fujioka Obesity
- Comorbidity associated with obesity in a large population: The APNA study
- (2015) Elena Martin-Rodriguez et al. Obesity Research & Clinical Practice
- Next Generation of Weight Management Medications: Implications for Diabetes and CVD Risk
- (2015) S. Wharton et al. Current Cardiology Reports
- Update on obesity pharmacotherapy
- (2014) George A. Bray et al. Annals of the New York Academy of Sciences
- Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus
- (2014) Nathaniel R. Smilowitz et al. CIRCULATION
- Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
- (2014) Guangwei Li et al. Lancet Diabetes & Endocrinology
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Elevated body mass index as a causal risk factor for symptomatic gallstone disease: A Mendelian randomization study
- (2013) Stefan Stender et al. HEPATOLOGY
- Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study
- (2013) K Johansson et al. INTERNATIONAL JOURNAL OF OBESITY
- Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
- (2013) T A Wadden et al. INTERNATIONAL JOURNAL OF OBESITY
- Long-term Drug Treatment for Obesity
- (2013) Susan Z. Yanovski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults
- (2013) Louis J. Aronne et al. Obesity
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
- (2013) M. Fried et al. OBESITY SURGERY
- Use of Prescription Antiobesity Drugs in the United States
- (2013) Christian Hampp et al. PHARMACOTHERAPY
- Risk of colorectal cancer after initiation of orlistat: matched cohort study
- (2013) J.-L. Hong et al. BMJ-British Medical Journal
- Obesity and Severe Obesity Forecasts Through 2030
- (2012) Eric A. Finkelstein et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation
- (2012) Lars Wichmann Madsen et al. ENDOCRINOLOGY
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus
- (2012) Peter A Banks et al. GUT
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults
- (2012) David H. Winslow et al. SLEEP
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
- (2011) R. R. Wing et al. DIABETES CARE
- Body mass index and the risk and prognosis of acute pancreatitis
- (2011) Shen Hong et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients
- (2010) Bankole A. Johnson et al. CURRENT PHARMACEUTICAL DESIGN
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates
- (2009) Eric A. Finkelstein et al. HEALTH AFFAIRS
- A proposed clinical staging system for obesity
- (2009) A M Sharma et al. INTERNATIONAL JOURNAL OF OBESITY
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Perioperative Safety in the Longitudinal Assessment of Bariatric Surgery
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- The Medical Risks of Obesity
- (2009) Xavier Pi-Sunyer POSTGRADUATE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started